

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NIK/NF-kappaB signaling (GO:0038061) | 7.30739913 |
| 2 | detection of molecule of bacterial origin (GO:0032490) | 5.98865173 |
| 3 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.23551785 |
| 4 | microglial cell activation (GO:0001774) | 4.90754261 |
| 5 | detection of external biotic stimulus (GO:0098581) | 4.84828937 |
| 6 | detection of other organism (GO:0098543) | 4.83892108 |
| 7 | response to peptidoglycan (GO:0032494) | 4.76610624 |
| 8 | negative regulation of interleukin-12 production (GO:0032695) | 4.67078744 |
| 9 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.62814455 |
| 10 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.61582012 |
| 11 | cellular extravasation (GO:0045123) | 4.57320505 |
| 12 | response to host immune response (GO:0052572) | 4.36610671 |
| 13 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.36610671 |
| 14 | growth hormone receptor signaling pathway (GO:0060396) | 4.36404464 |
| 15 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.33944100 |
| 16 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.33944100 |
| 17 | macrophage activation (GO:0042116) | 4.33543420 |
| 18 | detection of biotic stimulus (GO:0009595) | 4.25031585 |
| 19 | natural killer cell mediated cytotoxicity (GO:0042267) | 4.18426624 |
| 20 | natural killer cell mediated immunity (GO:0002228) | 4.18426624 |
| 21 | detection of bacterium (GO:0016045) | 4.17942742 |
| 22 | negative regulation of cell killing (GO:0031342) | 4.13088277 |
| 23 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.13088277 |
| 24 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 4.08722695 |
| 25 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 4.07196453 |
| 26 | positive regulation of B cell differentiation (GO:0045579) | 4.05485081 |
| 27 | myeloid dendritic cell differentiation (GO:0043011) | 4.04818508 |
| 28 | neutrophil mediated immunity (GO:0002446) | 4.01527699 |
| 29 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 4.01047532 |
| 30 | response to host (GO:0075136) | 3.95831452 |
| 31 | response to host defenses (GO:0052200) | 3.95831452 |
| 32 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.95831452 |
| 33 | myeloid dendritic cell activation (GO:0001773) | 3.94061363 |
| 34 | necroptotic process (GO:0070266) | 3.93132919 |
| 35 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.88707551 |
| 36 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.87156996 |
| 37 | neutrophil activation involved in immune response (GO:0002283) | 3.85216935 |
| 38 | mature B cell differentiation (GO:0002335) | 3.82150789 |
| 39 | negative thymic T cell selection (GO:0045060) | 3.77515451 |
| 40 | cellular response to growth hormone stimulus (GO:0071378) | 3.75760127 |
| 41 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.63560437 |
| 42 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.62068529 |
| 43 | leukocyte aggregation (GO:0070486) | 3.61741427 |
| 44 | negative regulation of T cell mediated immunity (GO:0002710) | 3.59838090 |
| 45 | neutrophil activation (GO:0042119) | 3.59134022 |
| 46 | regulation of RIG-I signaling pathway (GO:0039535) | 3.54358434 |
| 47 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.50654335 |
| 48 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.49791028 |
| 49 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.49724829 |
| 50 | positive regulation of antigen processing and presentation (GO:0002579) | 3.49018402 |
| 51 | dendritic cell differentiation (GO:0097028) | 3.47791081 |
| 52 | myeloid leukocyte mediated immunity (GO:0002444) | 3.47217242 |
| 53 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.46151914 |
| 54 | regulation of B cell differentiation (GO:0045577) | 3.46037911 |
| 55 | positive regulation of mast cell activation (GO:0033005) | 3.46023299 |
| 56 | regulation of mast cell degranulation (GO:0043304) | 3.44693414 |
| 57 | granulocyte activation (GO:0036230) | 3.44387374 |
| 58 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.43475564 |
| 59 | negative T cell selection (GO:0043383) | 3.42798768 |
| 60 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.41793454 |
| 61 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.41175791 |
| 62 | response to muramyl dipeptide (GO:0032495) | 3.39163884 |
| 63 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.38665249 |
| 64 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.37582108 |
| 65 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.37117360 |
| 66 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.33971967 |
| 67 | JAK-STAT cascade (GO:0007259) | 3.32046727 |
| 68 | T-helper 1 type immune response (GO:0042088) | 3.25664442 |
| 69 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.24363501 |
| 70 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.21818209 |
| 71 | cellular response to interleukin-15 (GO:0071350) | 3.21625874 |
| 72 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.21221127 |
| 73 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.20647422 |
| 74 | regulation of necroptotic process (GO:0060544) | 3.20287554 |
| 75 | regulation of mast cell activation (GO:0033003) | 3.20211901 |
| 76 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.18583131 |
| 77 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.18227605 |
| 78 | regulation of hypersensitivity (GO:0002883) | 3.14938560 |
| 79 | definitive hemopoiesis (GO:0060216) | 3.11091498 |
| 80 | programmed necrotic cell death (GO:0097300) | 3.09313815 |
| 81 | necrotic cell death (GO:0070265) | 3.08922111 |
| 82 | B cell receptor signaling pathway (GO:0050853) | 3.08845858 |
| 83 | regulation of leukocyte degranulation (GO:0043300) | 3.08658039 |
| 84 | positive regulation by symbiont of host defense response (GO:0052509) | 3.05089718 |
| 85 | modulation by symbiont of host defense response (GO:0052031) | 3.05089718 |
| 86 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.05089718 |
| 87 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.05089718 |
| 88 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.05089718 |
| 89 | modulation by symbiont of host immune response (GO:0052553) | 3.05089718 |
| 90 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.01927831 |
| 91 | positive regulation of mast cell degranulation (GO:0043306) | 3.01927831 |
| 92 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.01802176 |
| 93 | dendritic cell migration (GO:0036336) | 3.01729693 |
| 94 | macrophage activation involved in immune response (GO:0002281) | 3.00993119 |
| 95 | leukocyte mediated cytotoxicity (GO:0001909) | 2.96755131 |
| 96 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.95970933 |
| 97 | regulation of gamma-delta T cell activation (GO:0046643) | 2.94121464 |
| 98 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.93798450 |
| 99 | mature B cell differentiation involved in immune response (GO:0002313) | 2.92446599 |
| 100 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.90231722 |
| 101 | positive regulation of interferon-alpha production (GO:0032727) | 2.90124194 |
| 102 | positive thymic T cell selection (GO:0045059) | 2.89403479 |
| 103 | regulation of tolerance induction (GO:0002643) | 2.87698538 |
| 104 | regulation of macrophage cytokine production (GO:0010935) | 2.87427690 |
| 105 | myeloid cell activation involved in immune response (GO:0002275) | 2.86851958 |
| 106 | positive regulation of macrophage cytokine production (GO:0060907) | 2.84285052 |
| 107 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.83887116 |
| 108 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.83782340 |
| 109 | defense response to protozoan (GO:0042832) | 2.82835079 |
| 110 | T cell mediated immunity (GO:0002456) | 2.82800377 |
| 111 | positive regulation of interleukin-2 production (GO:0032743) | 2.82729454 |
| 112 | dendritic cell chemotaxis (GO:0002407) | 2.81926263 |
| 113 | neutrophil chemotaxis (GO:0030593) | 2.80274088 |
| 114 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.80231547 |
| 115 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.79965791 |
| 116 | regulation of antigen processing and presentation (GO:0002577) | 2.79346584 |
| 117 | leukocyte degranulation (GO:0043299) | 2.79289137 |
| 118 | lymphocyte migration (GO:0072676) | 2.78688995 |
| 119 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.77024490 |
| 120 | positive regulation of humoral immune response (GO:0002922) | 2.76898494 |
| 121 | germinal center formation (GO:0002467) | 2.75375461 |
| 122 | response to interleukin-15 (GO:0070672) | 2.74975207 |
| 123 | positive regulation of cell size (GO:0045793) | 2.74687772 |
| 124 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.74243581 |
| 125 | regulation of regulated secretory pathway (GO:1903305) | 2.73004547 |
| 126 | neutrophil migration (GO:1990266) | 2.72974522 |
| 127 | regulation of interferon-alpha production (GO:0032647) | 2.72780263 |
| 128 | energy homeostasis (GO:0097009) | 2.72689713 |
| 129 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.72072990 |
| 130 | T-helper cell differentiation (GO:0042093) | 2.72072990 |
| 131 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.71509747 |
| 132 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.71509747 |
| 133 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.71434062 |
| 134 | lymphocyte mediated immunity (GO:0002449) | 2.71125413 |
| 135 | immunoglobulin mediated immune response (GO:0016064) | 2.68537834 |
| 136 | positive regulation of interleukin-12 production (GO:0032735) | 2.67282248 |
| 137 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.65576265 |
| 138 | T cell homeostasis (GO:0043029) | 2.65442715 |
| 139 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.62966273 |
| 140 | response to type I interferon (GO:0034340) | 2.61421170 |
| 141 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.61390185 |
| 142 | negative regulation of interleukin-17 production (GO:0032700) | 2.60899319 |
| 143 | type I interferon signaling pathway (GO:0060337) | 2.59838348 |
| 144 | cellular response to type I interferon (GO:0071357) | 2.59838348 |
| 145 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.58864038 |
| 146 | B cell homeostasis (GO:0001782) | 2.58831404 |
| 147 | respiratory burst (GO:0045730) | 2.56070526 |
| 148 | T cell migration (GO:0072678) | 2.56036581 |
| 149 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 2.54604184 |
| 150 | myeloid leukocyte activation (GO:0002274) | 2.53952447 |
| 151 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.53549264 |
| 152 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.51337556 |
| 153 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.51203516 |
| 154 | megakaryocyte development (GO:0035855) | 2.49639587 |
| 155 | regulation of erythrocyte differentiation (GO:0045646) | 2.49209218 |
| 156 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.49193500 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.87112448 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.96380194 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.01161984 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.92432149 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.65192363 |
| 6 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.61762341 |
| 7 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.56382198 |
| 8 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.50875662 |
| 9 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.49025107 |
| 10 | GATA1_22025678_ChIP-Seq_K562_Human | 3.35156666 |
| 11 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.22360205 |
| 12 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.83171843 |
| 13 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.71964106 |
| 14 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.68449331 |
| 15 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.65197869 |
| 16 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.55045891 |
| 17 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.49458528 |
| 18 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.48998062 |
| 19 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.48389032 |
| 20 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.36767450 |
| 21 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.32390898 |
| 22 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.19800930 |
| 23 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.14849267 |
| 24 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.03346359 |
| 25 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.01889919 |
| 26 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.96481019 |
| 27 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.89969117 |
| 28 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.85637437 |
| 29 | SPI1_23127762_ChIP-Seq_K562_Human | 1.84110457 |
| 30 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.83050293 |
| 31 | MAF_26560356_Chip-Seq_TH1_Human | 1.81605769 |
| 32 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.80426562 |
| 33 | MYB_26560356_Chip-Seq_TH2_Human | 1.77803107 |
| 34 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.74701399 |
| 35 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.74250305 |
| 36 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.70487652 |
| 37 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.68114387 |
| 38 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.65357450 |
| 39 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.63835033 |
| 40 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.61598031 |
| 41 | MYB_26560356_Chip-Seq_TH1_Human | 1.61009799 |
| 42 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.58093243 |
| 43 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.57602281 |
| 44 | MYC_22102868_ChIP-Seq_BL_Human | 1.54982923 |
| 45 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.51785773 |
| 46 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.51445657 |
| 47 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.50295208 |
| 48 | GATA1_19941826_ChIP-Seq_K562_Human | 1.50198079 |
| 49 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.48826344 |
| 50 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.47763609 |
| 51 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.46898984 |
| 52 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.45543572 |
| 53 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.45435917 |
| 54 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.44416622 |
| 55 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.43706932 |
| 56 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.41503195 |
| 57 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.40445977 |
| 58 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.37649821 |
| 59 | GATA3_26560356_Chip-Seq_TH2_Human | 1.35612298 |
| 60 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.32573580 |
| 61 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.30399938 |
| 62 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.25842422 |
| 63 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.19158228 |
| 64 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.17732779 |
| 65 | UTX_26944678_Chip-Seq_JUKART_Human | 1.16627943 |
| 66 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.16245136 |
| 67 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.16217112 |
| 68 | GATA2_19941826_ChIP-Seq_K562_Human | 1.08872884 |
| 69 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.08106285 |
| 70 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06894495 |
| 71 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.06656937 |
| 72 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04791446 |
| 73 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.02210186 |
| 74 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.99599519 |
| 75 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.96974334 |
| 76 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.96410366 |
| 77 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.95385997 |
| 78 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.93476057 |
| 79 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.93184487 |
| 80 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.91847312 |
| 81 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.91154674 |
| 82 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.90527598 |
| 83 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.89669719 |
| 84 | * MAF_26560356_Chip-Seq_TH2_Human | 0.89307250 |
| 85 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.88868768 |
| 86 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.86742143 |
| 87 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.86129365 |
| 88 | * GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.80825399 |
| 89 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.78743543 |
| 90 | GATA3_26560356_Chip-Seq_TH1_Human | 0.78096293 |
| 91 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.77481410 |
| 92 | * KDM2B_26808549_Chip-Seq_K562_Human | 0.75764860 |
| 93 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.74841860 |
| 94 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.72577032 |
| 95 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.72113575 |
| 96 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.70697376 |
| 97 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.70099255 |
| 98 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.70047490 |
| 99 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.69489033 |
| 100 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.69332951 |
| 101 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.69278577 |
| 102 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.69156406 |
| 103 | RXR_22108803_ChIP-Seq_LS180_Human | 0.67900115 |
| 104 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.66801372 |
| 105 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.65420074 |
| 106 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.61891221 |
| 107 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.61187118 |
| 108 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.60610684 |
| 109 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.60380344 |
| 110 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.57323356 |
| 111 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.57180665 |
| 112 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.56447757 |
| 113 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.54804122 |
| 114 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.54019046 |
| 115 | * AR_25329375_ChIP-Seq_VCAP_Human | 0.53346951 |
| 116 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.53344302 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002138_abnormal_hepatobiliary_system | 4.31376500 |
| 2 | MP0000569_abnormal_digit_pigmentation | 4.14357367 |
| 3 | MP0001835_abnormal_antigen_presentation | 4.01604049 |
| 4 | MP0004510_myositis | 3.95751899 |
| 5 | MP0002254_reproductive_system_inflammat | 3.18529171 |
| 6 | MP0000685_abnormal_immune_system | 2.74066438 |
| 7 | MP0005174_abnormal_tail_pigmentation | 2.66364342 |
| 8 | MP0002166_altered_tumor_susceptibility | 2.65676932 |
| 9 | MP0003436_decreased_susceptibility_to | 2.50276039 |
| 10 | MP0008260_abnormal_autophagy | 2.49383164 |
| 11 | MP0005387_immune_system_phenotype | 2.45668840 |
| 12 | MP0001790_abnormal_immune_system | 2.45668840 |
| 13 | MP0001800_abnormal_humoral_immune | 2.39655661 |
| 14 | MP0002148_abnormal_hypersensitivity_rea | 2.32974535 |
| 15 | MP0005397_hematopoietic_system_phenotyp | 2.26859977 |
| 16 | MP0001545_abnormal_hematopoietic_system | 2.26859977 |
| 17 | MP0002452_abnormal_antigen_presenting | 2.25282990 |
| 18 | MP0002419_abnormal_innate_immunity | 2.24824260 |
| 19 | MP0005000_abnormal_immune_tolerance | 2.22273947 |
| 20 | MP0002009_preneoplasia | 2.21638192 |
| 21 | MP0001348_abnormal_lacrimal_gland | 2.19054051 |
| 22 | MP0005464_abnormal_platelet_physiology | 2.16373056 |
| 23 | MP0003303_peritoneal_inflammation | 2.15278150 |
| 24 | MP0005671_abnormal_response_to | 2.15100001 |
| 25 | MP0004381_abnormal_hair_follicle | 2.14837214 |
| 26 | MP0002723_abnormal_immune_serum | 2.09057166 |
| 27 | MP0003828_pulmonary_edema | 2.05545642 |
| 28 | MP0001819_abnormal_immune_cell | 2.00008157 |
| 29 | MP0005025_abnormal_response_to | 1.99867442 |
| 30 | MP0002420_abnormal_adaptive_immunity | 1.99155609 |
| 31 | MP0002006_tumorigenesis | 1.97010765 |
| 32 | MP0001968_abnormal_touch/_nociception | 1.94555979 |
| 33 | MP0009785_altered_susceptibility_to | 1.93433719 |
| 34 | MP0002396_abnormal_hematopoietic_system | 1.90490459 |
| 35 | MP0005451_abnormal_body_composition | 1.88518437 |
| 36 | MP0005310_abnormal_salivary_gland | 1.85940952 |
| 37 | MP0002398_abnormal_bone_marrow | 1.79815815 |
| 38 | MP0009278_abnormal_bone_marrow | 1.77659713 |
| 39 | MP0000604_amyloidosis | 1.75014629 |
| 40 | MP0002736_abnormal_nociception_after | 1.67790232 |
| 41 | MP0004883_abnormal_blood_vessel | 1.67450868 |
| 42 | MP0004808_abnormal_hematopoietic_stem | 1.66342155 |
| 43 | MP0000716_abnormal_immune_system | 1.66027679 |
| 44 | MP0003172_abnormal_lysosome_physiology | 1.63828102 |
| 45 | MP0004859_abnormal_synaptic_plasticity | 1.60667121 |
| 46 | MP0002877_abnormal_melanocyte_morpholog | 1.58366516 |
| 47 | MP0003191_abnormal_cellular_cholesterol | 1.56986701 |
| 48 | MP0003690_abnormal_glial_cell | 1.55614725 |
| 49 | MP0003283_abnormal_digestive_organ | 1.53304251 |
| 50 | MP0005058_abnormal_lysosome_morphology | 1.47104806 |
| 51 | MP0000015_abnormal_ear_pigmentation | 1.44145970 |
| 52 | MP0001853_heart_inflammation | 1.43765929 |
| 53 | MP0002132_abnormal_respiratory_system | 1.43034398 |
| 54 | MP0002163_abnormal_gland_morphology | 1.40780199 |
| 55 | MP0002735_abnormal_chemical_nociception | 1.39756637 |
| 56 | MP0000689_abnormal_spleen_morphology | 1.39655426 |
| 57 | MP0003300_gastrointestinal_ulcer | 1.38552262 |
| 58 | MP0003656_abnormal_erythrocyte_physiolo | 1.33842234 |
| 59 | MP0002429_abnormal_blood_cell | 1.33646958 |
| 60 | MP0000858_altered_metastatic_potential | 1.31883399 |
| 61 | MP0001873_stomach_inflammation | 1.30529432 |
| 62 | MP0001986_abnormal_taste_sensitivity | 1.28642163 |
| 63 | MP0005164_abnormal_response_to | 1.24374034 |
| 64 | MP0009333_abnormal_splenocyte_physiolog | 1.21521596 |
| 65 | MP0002722_abnormal_immune_system | 1.20687790 |
| 66 | MP0004947_skin_inflammation | 1.19886591 |
| 67 | MP0001845_abnormal_inflammatory_respons | 1.19132284 |
| 68 | MP0002095_abnormal_skin_pigmentation | 1.17026917 |
| 69 | MP0009764_decreased_sensitivity_to | 1.15301928 |
| 70 | MP0002405_respiratory_system_inflammati | 1.14743481 |
| 71 | MP0008469_abnormal_protein_level | 1.07568393 |
| 72 | MP0005075_abnormal_melanosome_morpholog | 1.07066217 |
| 73 | MP0001851_eye_inflammation | 1.06511174 |
| 74 | MP0000371_diluted_coat_color | 1.05346735 |
| 75 | MP0003724_increased_susceptibility_to | 1.04066552 |
| 76 | MP0006082_CNS_inflammation | 1.02448475 |
| 77 | MP0003183_abnormal_peptide_metabolism | 1.02341757 |
| 78 | MP0010155_abnormal_intestine_physiology | 1.02043197 |
| 79 | MP0003221_abnormal_cardiomyocyte_apopto | 0.98133706 |
| 80 | MP0003252_abnormal_bile_duct | 0.95085457 |
| 81 | MP0005166_decreased_susceptibility_to | 0.92668444 |
| 82 | MP0000465_gastrointestinal_hemorrhage | 0.91297979 |
| 83 | MP0003943_abnormal_hepatobiliary_system | 0.91233948 |
| 84 | MP0000343_altered_response_to | 0.89131397 |
| 85 | MP0001533_abnormal_skeleton_physiology | 0.88475539 |
| 86 | MP0002277_abnormal_respiratory_mucosa | 0.88161895 |
| 87 | MP0003329_amyloid_beta_deposits | 0.87495569 |
| 88 | MP0003045_fibrosis | 0.86878632 |
| 89 | MP0003763_abnormal_thymus_physiology | 0.86324241 |
| 90 | MP0005408_hypopigmentation | 0.85117723 |
| 91 | MP0005379_endocrine/exocrine_gland_phen | 0.82613735 |
| 92 | MP0000703_abnormal_thymus_morphology | 0.82253190 |
| 93 | MP0008874_decreased_physiological_sensi | 0.80433326 |
| 94 | MP0002733_abnormal_thermal_nociception | 0.78526821 |
| 95 | MP0003787_abnormal_imprinting | 0.77489722 |
| 96 | MP0003635_abnormal_synaptic_transmissio | 0.77305206 |
| 97 | MP0003448_altered_tumor_morphology | 0.77218374 |
| 98 | MP0005423_abnormal_somatic_nervous | 0.76914654 |
| 99 | MP0004858_abnormal_nervous_system | 0.75524262 |
| 100 | MP0003091_abnormal_cell_migration | 0.73798908 |
| 101 | MP0006054_spinal_hemorrhage | 0.73318028 |
| 102 | MP0008872_abnormal_physiological_respon | 0.73070089 |
| 103 | MP0004130_abnormal_muscle_cell | 0.72458452 |
| 104 | MP0003880_abnormal_central_pattern | 0.69003153 |
| 105 | MP0002998_abnormal_bone_remodeling | 0.68372796 |
| 106 | MP0005390_skeleton_phenotype | 0.68230644 |
| 107 | MP0002332_abnormal_exercise_endurance | 0.68029504 |
| 108 | MP0008877_abnormal_DNA_methylation | 0.67104612 |
| 109 | MP0009840_abnormal_foam_cell | 0.66956931 |
| 110 | MP0009046_muscle_twitch | 0.66914877 |
| 111 | MP0000920_abnormal_myelination | 0.66662385 |
| 112 | MP0003075_altered_response_to | 0.66316510 |
| 113 | MP0005167_abnormal_blood-brain_barrier | 0.65476692 |
| 114 | MP0001663_abnormal_digestive_system | 0.65078505 |
| 115 | MP0004484_altered_response_of | 0.64961977 |
| 116 | MP0008004_abnormal_stomach_pH | 0.64893316 |
| 117 | MP0005409_darkened_coat_color | 0.64027779 |
| 118 | MP0003866_abnormal_defecation | 0.62743431 |
| 119 | MP0002933_joint_inflammation | 0.61860980 |
| 120 | MP0009745_abnormal_behavioral_response | 0.61576483 |
| 121 | MP0002064_seizures | 0.61479121 |
| 122 | MP0009765_abnormal_xenobiotic_induced | 0.61132860 |
| 123 | MP0001970_abnormal_pain_threshold | 0.60571781 |
| 124 | MP0000249_abnormal_blood_vessel | 0.59899133 |
| 125 | MP0000372_irregular_coat_pigmentation | 0.59097242 |
| 126 | MP0003795_abnormal_bone_structure | 0.58119619 |
| 127 | MP0002133_abnormal_respiratory_system | 0.58094923 |
| 128 | MP0005388_respiratory_system_phenotype | 0.58094923 |
| 129 | MP0010352_gastrointestinal_tract_polyps | 0.57158371 |
| 130 | MP0002928_abnormal_bile_duct | 0.53264050 |
| 131 | MP0009763_increased_sensitivity_to | 0.52311535 |
| 132 | MP0002063_abnormal_learning/memory/cond | 0.52106555 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent bacterial skin infections (HP:0005406) | 4.87111237 |
| 2 | Recurrent abscess formation (HP:0002722) | 4.72501260 |
| 3 | Eczematoid dermatitis (HP:0000976) | 4.40198674 |
| 4 | Stomatitis (HP:0010280) | 4.19383202 |
| 5 | Recurrent fungal infections (HP:0002841) | 4.13913059 |
| 6 | Keratoconjunctivitis sicca (HP:0001097) | 3.93988587 |
| 7 | Recurrent viral infections (HP:0004429) | 3.90625104 |
| 8 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.72431297 |
| 9 | T lymphocytopenia (HP:0005403) | 3.68558886 |
| 10 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.68553011 |
| 11 | Increased cerebral lipofuscin (HP:0011813) | 3.66870234 |
| 12 | Keratoconjunctivitis (HP:0001096) | 3.62579301 |
| 13 | Mediastinal lymphadenopathy (HP:0100721) | 3.57611291 |
| 14 | Gingival bleeding (HP:0000225) | 3.56968787 |
| 15 | Abnormality of T cell number (HP:0011839) | 3.47743388 |
| 16 | Abnormality of glycolipid metabolism (HP:0010969) | 3.42278019 |
| 17 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.42278019 |
| 18 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.42278019 |
| 19 | Thrombocytosis (HP:0001894) | 3.39904217 |
| 20 | Fatigue (HP:0012378) | 3.35987541 |
| 21 | Recurrent skin infections (HP:0001581) | 3.30920830 |
| 22 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.23229767 |
| 23 | Prolonged bleeding time (HP:0003010) | 3.18142463 |
| 24 | Peritonitis (HP:0002586) | 3.15035273 |
| 25 | Myocardial infarction (HP:0001658) | 3.13668787 |
| 26 | Hemoptysis (HP:0002105) | 3.13272900 |
| 27 | Urticaria (HP:0001025) | 3.10069587 |
| 28 | Autoimmune thrombocytopenia (HP:0001973) | 3.00733154 |
| 29 | Periodontitis (HP:0000704) | 3.00276792 |
| 30 | Abnormality of macrophages (HP:0004311) | 2.98450602 |
| 31 | Recurrent cutaneous fungal infections (HP:0011370) | 2.91456040 |
| 32 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.91456040 |
| 33 | Chronic otitis media (HP:0000389) | 2.89747838 |
| 34 | Vasculitis (HP:0002633) | 2.89537497 |
| 35 | Agammaglobulinemia (HP:0004432) | 2.87041981 |
| 36 | Visual hallucinations (HP:0002367) | 2.86755427 |
| 37 | Epistaxis (HP:0000421) | 2.84980779 |
| 38 | Arterial thrombosis (HP:0004420) | 2.83568259 |
| 39 | Cellulitis (HP:0100658) | 2.79183082 |
| 40 | Hematochezia (HP:0002573) | 2.78809053 |
| 41 | Myositis (HP:0100614) | 2.77256042 |
| 42 | Pulmonary embolism (HP:0002204) | 2.74903256 |
| 43 | Colitis (HP:0002583) | 2.73280535 |
| 44 | Gingivitis (HP:0000230) | 2.72557044 |
| 45 | Progressive inability to walk (HP:0002505) | 2.70167484 |
| 46 | Optic neuritis (HP:0100653) | 2.64929436 |
| 47 | Retrobulbar optic neuritis (HP:0100654) | 2.64929436 |
| 48 | Abnormality of the thoracic spine (HP:0100711) | 2.63500415 |
| 49 | Absent frontal sinuses (HP:0002688) | 2.62460783 |
| 50 | Panhypogammaglobulinemia (HP:0003139) | 2.62408783 |
| 51 | Petechiae (HP:0000967) | 2.59441732 |
| 52 | Episodic fever (HP:0001954) | 2.57648066 |
| 53 | Increased IgE level (HP:0003212) | 2.56924912 |
| 54 | Gastrointestinal infarctions (HP:0005244) | 2.52596368 |
| 55 | Acute myeloid leukemia (HP:0004808) | 2.51505811 |
| 56 | Anorexia (HP:0002039) | 2.50902318 |
| 57 | Gangrene (HP:0100758) | 2.49779336 |
| 58 | Meningitis (HP:0001287) | 2.49435542 |
| 59 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.47449716 |
| 60 | Abnormality of the peritoneum (HP:0002585) | 2.47305006 |
| 61 | Abnormality of T cells (HP:0002843) | 2.46118198 |
| 62 | Orchitis (HP:0100796) | 2.45225586 |
| 63 | Leukocytosis (HP:0001974) | 2.43626801 |
| 64 | Abnormality of the fingertips (HP:0001211) | 2.43280365 |
| 65 | Pulmonary infiltrates (HP:0002113) | 2.42711368 |
| 66 | Polycythemia (HP:0001901) | 2.40890878 |
| 67 | Hypochromic microcytic anemia (HP:0004840) | 2.38865337 |
| 68 | Prostate neoplasm (HP:0100787) | 2.37677064 |
| 69 | Inflammation of the large intestine (HP:0002037) | 2.37229007 |
| 70 | Subacute progressive viral hepatitis (HP:0006572) | 2.36633704 |
| 71 | Abnormal platelet function (HP:0011869) | 2.32006130 |
| 72 | Impaired platelet aggregation (HP:0003540) | 2.32006130 |
| 73 | Abnormality of the pleura (HP:0002103) | 2.28266820 |
| 74 | Nasal polyposis (HP:0100582) | 2.27043888 |
| 75 | Chronic obstructive pulmonary disease (HP:0006510) | 2.26656783 |
| 76 | Obstructive lung disease (HP:0006536) | 2.26656783 |
| 77 | Supranuclear gaze palsy (HP:0000605) | 2.24400951 |
| 78 | Abnormality of the columella (HP:0009929) | 2.23980013 |
| 79 | Anhidrosis (HP:0000970) | 2.23723502 |
| 80 | Slow saccadic eye movements (HP:0000514) | 2.23279886 |
| 81 | Osteomyelitis (HP:0002754) | 2.21833304 |
| 82 | Gastrointestinal stroma tumor (HP:0100723) | 2.21348222 |
| 83 | Spontaneous hematomas (HP:0007420) | 2.21282164 |
| 84 | Glomerulopathy (HP:0100820) | 2.20623358 |
| 85 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.20489265 |
| 86 | Dysostosis multiplex (HP:0000943) | 2.20234672 |
| 87 | Gastrointestinal inflammation (HP:0004386) | 2.19212709 |
| 88 | Abnormality of the periventricular white matter (HP:0002518) | 2.19012428 |
| 89 | Viral hepatitis (HP:0006562) | 2.16116442 |
| 90 | Chest pain (HP:0100749) | 2.15144437 |
| 91 | Cerebral hemorrhage (HP:0001342) | 2.14072061 |
| 92 | Tetraparesis (HP:0002273) | 2.13447668 |
| 93 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.12659194 |
| 94 | Abnormality of the endocardium (HP:0004306) | 2.10931278 |
| 95 | Abnormality of the nasal mucosa (HP:0000433) | 2.10821675 |
| 96 | Increased IgM level (HP:0003496) | 2.10397726 |
| 97 | Spontaneous abortion (HP:0005268) | 2.09639918 |
| 98 | Hypochromic anemia (HP:0001931) | 2.09009408 |
| 99 | Sepsis (HP:0100806) | 2.06884081 |
| 100 | Recurrent bronchitis (HP:0002837) | 2.06733693 |
| 101 | Loss of speech (HP:0002371) | 2.05712249 |
| 102 | Menorrhagia (HP:0000132) | 2.04246549 |
| 103 | Mucopolysacchariduria (HP:0008155) | 2.03358653 |
| 104 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.03358653 |
| 105 | Cortical dysplasia (HP:0002539) | 2.03212105 |
| 106 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.01447755 |
| 107 | Interstitial pulmonary disease (HP:0006530) | 2.00736441 |
| 108 | Vertigo (HP:0002321) | 2.00000501 |
| 109 | Granulocytopenia (HP:0001913) | 1.99570165 |
| 110 | Polyneuropathy (HP:0001271) | 1.99288446 |
| 111 | Vacuolated lymphocytes (HP:0001922) | 1.97355856 |
| 112 | Amyloidosis (HP:0011034) | 1.97140155 |
| 113 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.96420356 |
| 114 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.96420356 |
| 115 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.96420356 |
| 116 | Papilledema (HP:0001085) | 1.96316544 |
| 117 | Disinhibition (HP:0000734) | 1.96113045 |
| 118 | Submucous cleft hard palate (HP:0000176) | 1.95433246 |
| 119 | Acne (HP:0001061) | 1.93244858 |
| 120 | Hypergammaglobulinemia (HP:0010702) | 1.91819066 |
| 121 | Ocular albinism (HP:0001107) | 1.91090717 |
| 122 | Eosinophilia (HP:0001880) | 1.90297619 |
| 123 | Pustule (HP:0200039) | 1.89767233 |
| 124 | Cheilitis (HP:0100825) | 1.89331790 |
| 125 | Focal motor seizures (HP:0011153) | 1.89151099 |
| 126 | Keratitis (HP:0000491) | 1.88352161 |
| 127 | Febrile seizures (HP:0002373) | 1.88347739 |
| 128 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.88254274 |
| 129 | Encephalitis (HP:0002383) | 1.87870341 |
| 130 | Abnormal platelet volume (HP:0011876) | 1.87790507 |
| 131 | Microcytic anemia (HP:0001935) | 1.86747007 |
| 132 | Abnormal hair whorl (HP:0010721) | 1.84586051 |
| 133 | Focal seizures (HP:0007359) | 1.84378760 |
| 134 | Iris hypopigmentation (HP:0007730) | 1.84226997 |
| 135 | Sensorimotor neuropathy (HP:0007141) | 1.83985213 |
| 136 | Thyroiditis (HP:0100646) | 1.83919527 |
| 137 | Thrombophlebitis (HP:0004418) | 1.83024398 |
| 138 | Recurrent pneumonia (HP:0006532) | 1.81916591 |
| 139 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.79380179 |
| 140 | Acute hepatic failure (HP:0006554) | 1.77919282 |
| 141 | Purpura (HP:0000979) | 1.76765209 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 3.82684469 |
| 2 | RIPK4 | 3.51584829 |
| 3 | MAP3K13 | 3.48872638 |
| 4 | TYK2 | 2.91559902 |
| 5 | JAK3 | 2.78835930 |
| 6 | KIT | 2.65888258 |
| 7 | NTRK3 | 2.65447888 |
| 8 | IKBKB | 2.57179038 |
| 9 | TBK1 | 2.28137173 |
| 10 | KSR2 | 2.27910853 |
| 11 | MAP4K1 | 2.27313761 |
| 12 | BRD4 | 2.17185376 |
| 13 | IKBKE | 2.16006101 |
| 14 | TAOK3 | 2.06635986 |
| 15 | JAK1 | 2.05202992 |
| 16 | IRAK4 | 1.98839465 |
| 17 | RET | 1.93927405 |
| 18 | PRPF4B | 1.88497911 |
| 19 | CHUK | 1.87110112 |
| 20 | ERN1 | 1.80433268 |
| 21 | TXK | 1.78709733 |
| 22 | SYK | 1.75255957 |
| 23 | MAP3K2 | 1.72521073 |
| 24 | MAP3K9 | 1.63570388 |
| 25 | CSF1R | 1.60259481 |
| 26 | FGFR3 | 1.51809223 |
| 27 | MAP3K3 | 1.45198730 |
| 28 | SIK2 | 1.44947054 |
| 29 | MATK | 1.43928347 |
| 30 | MAP3K6 | 1.37952205 |
| 31 | JAK2 | 1.36351060 |
| 32 | FES | 1.35907277 |
| 33 | IRAK2 | 1.35622165 |
| 34 | MAP3K12 | 1.32793153 |
| 35 | ZAP70 | 1.32620192 |
| 36 | TAOK1 | 1.32381652 |
| 37 | MAP2K3 | 1.29683973 |
| 38 | PRKCH | 1.25948516 |
| 39 | MAP3K11 | 1.21976273 |
| 40 | EPHA3 | 1.21912995 |
| 41 | FLT3 | 1.19468018 |
| 42 | BTK | 1.16652742 |
| 43 | MAP2K4 | 1.16238370 |
| 44 | BLK | 1.13638968 |
| 45 | MARK3 | 1.13450247 |
| 46 | PIK3CG | 1.09210043 |
| 47 | PRKD2 | 1.07779027 |
| 48 | ITK | 1.05520987 |
| 49 | RAF1 | 1.04812224 |
| 50 | TGFBR2 | 0.99721419 |
| 51 | FGFR4 | 0.99474884 |
| 52 | NEK9 | 0.99064006 |
| 53 | MAP2K6 | 0.98458166 |
| 54 | EPHB1 | 0.98106724 |
| 55 | LCK | 0.95831744 |
| 56 | MARK2 | 0.94603036 |
| 57 | HCK | 0.94235705 |
| 58 | MAP3K1 | 0.93907926 |
| 59 | SGK3 | 0.93321930 |
| 60 | PRKAA2 | 0.88865678 |
| 61 | DAPK2 | 0.87508620 |
| 62 | PIM1 | 0.86702745 |
| 63 | MINK1 | 0.86128316 |
| 64 | ACVR1B | 0.85516596 |
| 65 | WNK1 | 0.85146718 |
| 66 | MAP2K7 | 0.81214407 |
| 67 | SGK1 | 0.75182182 |
| 68 | SGK2 | 0.73910202 |
| 69 | MAP3K5 | 0.73775878 |
| 70 | TEC | 0.72440624 |
| 71 | HIPK2 | 0.72401398 |
| 72 | SIK3 | 0.71164806 |
| 73 | RPS6KA2 | 0.71114904 |
| 74 | CAMKK2 | 0.71106958 |
| 75 | BMX | 0.70302665 |
| 76 | PTK2B | 0.69509894 |
| 77 | PDK1 | 0.68562877 |
| 78 | NLK | 0.68160936 |
| 79 | CDK9 | 0.67887405 |
| 80 | GRK7 | 0.67082232 |
| 81 | CDK19 | 0.66945027 |
| 82 | SCYL2 | 0.66417388 |
| 83 | GRK6 | 0.66132463 |
| 84 | DAPK1 | 0.65229668 |
| 85 | LYN | 0.63235478 |
| 86 | YES1 | 0.61402801 |
| 87 | PKN1 | 0.60288810 |
| 88 | PTK6 | 0.59485767 |
| 89 | MAP3K4 | 0.59476297 |
| 90 | TAOK2 | 0.56527353 |
| 91 | SGK223 | 0.54387096 |
| 92 | SGK494 | 0.54387096 |
| 93 | MAPK7 | 0.53807398 |
| 94 | MAPK12 | 0.52282227 |
| 95 | STK10 | 0.51057781 |
| 96 | LRRK2 | 0.50993994 |
| 97 | BMPR2 | 0.50693985 |
| 98 | FRK | 0.50532971 |
| 99 | PRKCZ | 0.50469521 |
| 100 | KSR1 | 0.50453008 |
| 101 | CDC42BPA | 0.49894104 |
| 102 | TRIB3 | 0.49652176 |
| 103 | PRKCD | 0.48296199 |
| 104 | TNK2 | 0.48128304 |
| 105 | CAMKK1 | 0.46645614 |
| 106 | MARK1 | 0.45483550 |
| 107 | DYRK1B | 0.45227687 |
| 108 | NTRK1 | 0.44849680 |
| 109 | GRK5 | 0.44685457 |
| 110 | STK24 | 0.43695577 |
| 111 | STK11 | 0.43608946 |
| 112 | RPS6KL1 | 0.42108881 |
| 113 | RPS6KC1 | 0.42108881 |
| 114 | IRAK1 | 0.40118282 |
| 115 | CDK5 | 0.39656049 |
| 116 | PKN2 | 0.39159107 |
| 117 | MAP3K7 | 0.38851777 |
| 118 | ALK | 0.38632212 |
| 119 | EGFR | 0.38621440 |
| 120 | IRAK3 | 0.38458396 |
| 121 | CAMK4 | 0.37749891 |
| 122 | PRKCE | 0.37433878 |
| 123 | PDPK1 | 0.36492696 |
| 124 | TGFBR1 | 0.36205760 |
| 125 | GSK3A | 0.35657020 |
| 126 | PRKCQ | 0.35631025 |
| 127 | FYN | 0.34636425 |
| 128 | MUSK | 0.33647285 |
| 129 | STK4 | 0.33614360 |
| 130 | CSK | 0.33006094 |
| 131 | MAPK4 | 0.33005391 |
| 132 | CDK6 | 0.32852852 |
| 133 | RIPK1 | 0.32205865 |
| 134 | RPS6KA6 | 0.31767350 |
| 135 | FGR | 0.31616201 |
| 136 | RPS6KA1 | 0.30216587 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 2.75019888 |
| 2 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.34782828 |
| 3 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.33893586 |
| 4 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.30163175 |
| 5 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.03364314 |
| 6 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.96029877 |
| 7 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.78904349 |
| 8 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.77801584 |
| 9 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.77645727 |
| 10 | Measles_Homo sapiens_hsa05162 | 1.76170282 |
| 11 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.74920835 |
| 12 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.68632652 |
| 13 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.65798074 |
| 14 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.58928630 |
| 15 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.56574237 |
| 16 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.56072217 |
| 17 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.54278056 |
| 18 | Tuberculosis_Homo sapiens_hsa05152 | 1.52238688 |
| 19 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.50844900 |
| 20 | Allograft rejection_Homo sapiens_hsa05330 | 1.50711650 |
| 21 | Apoptosis_Homo sapiens_hsa04210 | 1.49450108 |
| 22 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.42994934 |
| 23 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.42855508 |
| 24 | Other glycan degradation_Homo sapiens_hsa00511 | 1.42517436 |
| 25 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.41043608 |
| 26 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.40018005 |
| 27 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.39228607 |
| 28 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.38935221 |
| 29 | Pertussis_Homo sapiens_hsa05133 | 1.38319000 |
| 30 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.37029836 |
| 31 | Platelet activation_Homo sapiens_hsa04611 | 1.32240833 |
| 32 | Influenza A_Homo sapiens_hsa05164 | 1.30967622 |
| 33 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.27502126 |
| 34 | Shigellosis_Homo sapiens_hsa05131 | 1.25981268 |
| 35 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.21203188 |
| 36 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.19757919 |
| 37 | Asthma_Homo sapiens_hsa05310 | 1.18729638 |
| 38 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.14790787 |
| 39 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.13843446 |
| 40 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.11147744 |
| 41 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.11128072 |
| 42 | Hepatitis B_Homo sapiens_hsa05161 | 1.06368303 |
| 43 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.05562455 |
| 44 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.04731701 |
| 45 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.04285161 |
| 46 | Morphine addiction_Homo sapiens_hsa05032 | 1.02621943 |
| 47 | Olfactory transduction_Homo sapiens_hsa04740 | 1.01593196 |
| 48 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.00574561 |
| 49 | Salmonella infection_Homo sapiens_hsa05132 | 1.00237299 |
| 50 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.96181158 |
| 51 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.93089429 |
| 52 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.92378972 |
| 53 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.92366825 |
| 54 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.91945002 |
| 55 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.91898297 |
| 56 | Circadian entrainment_Homo sapiens_hsa04713 | 0.87219730 |
| 57 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.85521692 |
| 58 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.84561025 |
| 59 | Glioma_Homo sapiens_hsa05214 | 0.83883342 |
| 60 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.83852012 |
| 61 | Hepatitis C_Homo sapiens_hsa05160 | 0.82769674 |
| 62 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.82647590 |
| 63 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.82178610 |
| 64 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.82164927 |
| 65 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.81842561 |
| 66 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.81656859 |
| 67 | Renin secretion_Homo sapiens_hsa04924 | 0.81145768 |
| 68 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.80640959 |
| 69 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.76885179 |
| 70 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.76434644 |
| 71 | Lysosome_Homo sapiens_hsa04142 | 0.76175201 |
| 72 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.76041623 |
| 73 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.75034173 |
| 74 | Nicotine addiction_Homo sapiens_hsa05033 | 0.73752144 |
| 75 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.73731876 |
| 76 | Phagosome_Homo sapiens_hsa04145 | 0.73638562 |
| 77 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.72001976 |
| 78 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.71076745 |
| 79 | Endometrial cancer_Homo sapiens_hsa05213 | 0.70876871 |
| 80 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.70462192 |
| 81 | Long-term potentiation_Homo sapiens_hsa04720 | 0.69790250 |
| 82 | Viral myocarditis_Homo sapiens_hsa05416 | 0.69332317 |
| 83 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.69132212 |
| 84 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.69066592 |
| 85 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.68157530 |
| 86 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.66995005 |
| 87 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.66702498 |
| 88 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.65741156 |
| 89 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.65436627 |
| 90 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.64962853 |
| 91 | Amoebiasis_Homo sapiens_hsa05146 | 0.64904368 |
| 92 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.64481101 |
| 93 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.62734037 |
| 94 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.62528060 |
| 95 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.62359931 |
| 96 | GABAergic synapse_Homo sapiens_hsa04727 | 0.61472412 |
| 97 | Legionellosis_Homo sapiens_hsa05134 | 0.61437583 |
| 98 | Endocytosis_Homo sapiens_hsa04144 | 0.61025996 |
| 99 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.60441698 |
| 100 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.59889707 |
| 101 | Insulin resistance_Homo sapiens_hsa04931 | 0.59801034 |
| 102 | Malaria_Homo sapiens_hsa05144 | 0.59756791 |
| 103 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.58972687 |
| 104 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.58855509 |
| 105 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.57799126 |
| 106 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.57223725 |
| 107 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.57131913 |
| 108 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.56966600 |
| 109 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.56947949 |
| 110 | Salivary secretion_Homo sapiens_hsa04970 | 0.55204113 |
| 111 | Long-term depression_Homo sapiens_hsa04730 | 0.55011620 |
| 112 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.54784707 |
| 113 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.54011337 |
| 114 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.53100723 |
| 115 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.52300604 |
| 116 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.51651689 |
| 117 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.50879888 |
| 118 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.49770821 |
| 119 | Prostate cancer_Homo sapiens_hsa05215 | 0.46884779 |
| 120 | Colorectal cancer_Homo sapiens_hsa05210 | 0.42810646 |
| 121 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.38126662 |
| 122 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.35179318 |

